IRIS
SALTARELLA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.552
AS - Asia 1.162
EU - Europa 847
SA - Sud America 293
AF - Africa 63
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.489
SG - Singapore 499
CN - Cina 276
BR - Brasile 258
RU - Federazione Russa 192
IT - Italia 160
SE - Svezia 152
HK - Hong Kong 140
VN - Vietnam 108
DE - Germania 86
GB - Regno Unito 54
FI - Finlandia 49
FR - Francia 41
ID - Indonesia 38
CA - Canada 33
BE - Belgio 27
CI - Costa d'Avorio 24
IN - India 23
PL - Polonia 20
MX - Messico 19
ZA - Sudafrica 17
TR - Turchia 14
AR - Argentina 13
ES - Italia 12
LT - Lituania 12
JP - Giappone 10
NL - Olanda 9
AT - Austria 8
BD - Bangladesh 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
UZ - Uzbekistan 6
CO - Colombia 5
JO - Giordania 5
UA - Ucraina 5
VE - Venezuela 5
IE - Irlanda 4
IR - Iran 4
SA - Arabia Saudita 4
BH - Bahrain 3
CL - Cile 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
KE - Kenya 3
NO - Norvegia 3
PY - Paraguay 3
AU - Australia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JM - Giamaica 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.920
Salva come PNG Salva come JPEG
Città #
Ashburn 417
Singapore 263
Fairfield 229
Chandler 219
Woodbridge 147
Hong Kong 137
Beijing 133
Nyköping 129
Seattle 116
Cambridge 106
Ann Arbor 104
Wilmington 102
Houston 99
New York 80
Bari 73
Los Angeles 71
Dallas 45
Munich 37
Jakarta 36
Brooklyn 34
Ho Chi Minh City 32
Helsinki 31
Roxbury 31
Lawrence 30
Brussels 27
São Paulo 27
Nanjing 25
Abidjan 24
Dong Ket 23
Santa Clara 21
Moscow 20
Hanoi 19
Des Moines 17
London 17
Chicago 16
San Diego 15
Buffalo 14
Dearborn 14
Frankfurt am Main 14
Johannesburg 14
Grottaglie 13
Stockholm 13
Washington 13
Council Bluffs 12
Inglewood 12
Toronto 12
Salvador 11
Turku 11
Warsaw 11
Denver 10
Marseille 10
The Dalles 10
Tokyo 10
Curitiba 9
Montreal 9
Phoenix 9
San Jose 9
Chennai 8
Columbus 8
Jacksonville 8
Nuremberg 8
Poplar 8
Princeton 8
Rio de Janeiro 8
Guangzhou 7
Jiaxing 7
Mexico City 7
Paris 7
Rome 7
Boston 6
Falkenstein 6
Haiphong 6
Orem 6
Secaucus 6
Vienna 6
Amman 5
Ankara 5
Brasília 5
Florence 5
Sorocaba 5
Atlanta 4
Augusta 4
Boardman 4
Dublin 4
Grafing 4
Milan 4
Porto Alegre 4
Pune 4
Radomsko 4
Raleigh 4
San Francisco 4
São José dos Campos 4
Tashkent 4
Amsterdam 3
Baghdad 3
Barletta 3
Bauru 3
Bismarck 3
Brno 3
Changsha 3
Totale 3.417
Salva come PNG Salva come JPEG
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 197
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 188
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 166
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 165
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 157
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 155
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 152
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 151
Identify multiple myeloma stem cells: Utopia? 146
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 139
Bortezomib treatment modulates autophagy in multiple myeloma 128
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 126
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 123
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 120
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 119
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 116
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 112
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 112
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 110
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 109
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 109
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 105
null 101
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 96
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 95
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 95
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 87
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 86
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 84
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 83
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 83
Drug repurposing in skeletal muscle ion channelopathies 80
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 80
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 80
Antiangiogenic drugs as chemosensitizers in hematological tumors 78
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 75
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 71
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 68
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 67
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 63
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 59
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 59
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 58
The “angiogenic switch” from MGUS to MM: what about the Notch role? 56
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 53
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 52
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 52
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 52
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 50
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 46
Pharmacological therapy of non-dystrophic myotonias 37
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 36
Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies? 32
null 31
null 30
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 25
NSAIDS AS MODULATORS OF CATION CHANNELS: FENAMATES REPURPOSING IN CHANNELOPATHIES 24
Totale 5.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021296 0 0 0 0 0 30 39 47 25 71 38 46
2021/2022282 20 21 3 11 9 18 18 16 23 22 40 81
2022/2023560 52 89 45 44 51 70 11 74 84 11 15 14
2023/2024305 15 34 18 23 48 114 8 7 5 7 8 18
2024/20251.318 47 24 63 64 90 115 239 156 48 67 155 250
2025/20261.439 394 124 170 265 333 153 0 0 0 0 0 0
Totale 5.229